Related references
Note: Only part of the references are listed.Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis
Aldo A. Rodriguez-Menchaca et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Interaction of mephedrone with dopamine and serotonin targets in rats
Jose Martinez-Clemente et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats
J. Kehr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States
Henry A. Spiller et al.
CLINICAL TOXICOLOGY (2011)
4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse
Gregory C. Hadlock et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Khat - a controversial plant
Erica E. Balint et al.
WIENER KLINISCHE WOCHENSCHRIFT (2009)
Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes:: The proton inactivation hypothesis of hCHT in synaptic vesicles
Hideki Iwamoto et al.
JOURNAL OF NEUROSCIENCE (2006)
1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors
PC Meltzer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Share Paper
